Ionis Pharmaceuticals (IONS) Current Assets (2009 - 2026)

Ionis Pharmaceuticals' Current Assets history runs 18 years deep, the most recent figure standing at $2.9 billion for Q1 2026.

• In Q1 2026, Current Assets rose 21.41% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $2.9 billion (up 21.41% YoY), while the FY2025 annual figure was $3.0 billion, up 14.13% from the prior year.
• Current Assets was $2.9 billion for Q1 2026 at Ionis Pharmaceuticals, down from $3.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.0 billion in Q4 2025 to a low of $2.2 billion in Q3 2022.
• Historically, Current Assets has averaged $2.5 billion across 5 years, with a median of $2.5 billion in 2023.
• The sharpest annual moves came in 2024 and 2026: Current Assets decreased 10.98% in 2024, then increased 21.41% in 2026.
• A 5-year view of Current Assets shows it stood at $2.2 billion in 2022, then climbed by 19.94% to $2.6 billion in 2023, then slipped by 0.82% to $2.6 billion in 2024, then advanced by 14.13% to $3.0 billion in 2025, then declined by 1.8% to $2.9 billion in 2026.
• The last three Current Assets figures came in at $2.9 billion (Q1 2026), $3.0 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.